EXELIXIS, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Senner Christopher J. | EVP and CFO | Award / Grant | 32,567 | — | — | 424,101 | Sep 30, 2021 |
| Hessekiel Jeffrey | EVP and General Counsel | Tax Withholding | 7,593 | $20.63 | $156,644 | 650,825 | Sep 30, 2021 |
| Haley Patrick J. | EVP, Commercial | Tax Withholding | 5,416 | $20.63 | $111,732 | 304,528 | Sep 30, 2021 |
| Lamb Peter | EVP, Scientific Strategy & CSO | Tax Withholding | 7,177 | $20.63 | $148,062 | 411,240 | Sep 30, 2021 |
| Senner Christopher J. | EVP and CFO | Option Exercise | 90,000 | $3.66 | $329,400 | 446,591 | Sep 21, 2021 |
| Haley Patrick J. | EVP, Commercial | Sale | 25,000 | $20.36 | $509,000 | 280,994 | Sep 16, 2021 |
| Lamb Peter | EVP, Scientific Strategy & CSO | Sale | 47,500 | $20.46 | $971,850 | 389,467 | Sep 15, 2021 |
| Lamb Peter | EVP, Scientific Strategy & CSO | Option Exercise | 55,000 | $1.90 | $104,500 | 444,467 | Aug 16, 2021 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Option Exercise | 40,000 | $4.20 | $168,000 | 689,078 | Jul 26, 2021 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Option Exercise | 35,000 | $4.20 | $147,000 | 649,078 | Jul 21, 2021 |
| Lamb Peter | EVP, Scientific Strategy & CSO | Option Exercise | 60,000 | $1.90 | $114,000 | 449,467 | Jul 15, 2021 |
| COHEN CHARLES | — | Option Exercise | 40,000 | $3.13 | $125,200 | 221,375 | Jul 6, 2021 |
| Lamb Peter | EVP, Scientific Strategy & CSO | Option Exercise | 60,000 | $1.90 | $114,000 | 449,467 | Jun 17, 2021 |
| WYSZOMIERSKI JACK L | — | Award / Grant | 8,299 | — | — | 239,888 | May 27, 2021 |
| MARCHESI VINCENT T | — | Award / Grant | 8,299 | — | — | 74,414 | May 27, 2021 |
| PAPADOPOULOS STELIOS | — | Award / Grant | 16,424 | — | — | 1,304,551 | May 27, 2021 |
| Freire Maria C | — | Award / Grant | 8,299 | — | — | 40,126 | May 27, 2021 |
| POSTE GEORGE | — | Award / Grant | 16,424 | — | — | 173,614 | May 27, 2021 |
| Smith Julie | — | Award / Grant | 16,424 | — | — | 32,725 | May 27, 2021 |
| Hessekiel Jeffrey | EVP, General Counsel & Sec | Sale | 18,000 | $20.07 | $361,260 | 586,822 | May 17, 2021 |
| Haley Patrick J. | EVP, Commercial | Sale | 14,593 | $24.73 | $360,885 | 280,994 | May 15, 2021 |
| MARCHESI VINCENT T | — | Option Exercise | 40,000 | $6.30 | $252,000 | 106,115 | May 14, 2021 |
| POSTE GEORGE | — | Sale | 40,802 | $24.97 | $1,018,826 | 157,190 | May 14, 2021 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Option Exercise | 100,000 | $1.90 | $190,000 | 714,078 | May 13, 2021 |
| MORRISSEY MICHAEL | President and CEO | Gift | 19,722 | — | — | 1,038,789 | May 12, 2021 |
| Freire Maria C | — | Sale | 8,275 | $25.01 | $206,958 | 31,827 | May 11, 2021 |
| PAPADOPOULOS STELIOS | — | Option Exercise | 40,000 | $3.38 | $135,200 | 1,293,600 | May 11, 2021 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Sale | 50,000 | $25.00 | $1,250,000 | 613,482 | Apr 26, 2021 |
| Haley Patrick J. | EVP, Commercial | Sale | 7,665 | $25.03 | $191,855 | 297,392 | Apr 26, 2021 |
| Hessekiel Jeffrey | EVP and General Counsel | Sale | 18,000 | $25.03 | $450,540 | 628,248 | Apr 26, 2021 |
| Lamb Peter | EVP, Scientific Strategy & CSO | Option Exercise | 60,000 | $1.70 | $102,000 | 449,467 | Apr 1, 2021 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Sale | 50,000 | $23.00 | $1,150,000 | 613,482 | Apr 1, 2021 |
| WYSZOMIERSKI JACK L | — | Sale | 6,220 | $22.64 | $140,821 | 231,589 | Mar 29, 2021 |
| Garber Alan M | — | Option Exercise | 40,000 | $3.38 | $135,200 | 52,718 | Mar 15, 2021 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Award / Grant | 72,885 | — | — | 613,482 | Mar 4, 2021 |
| Hessekiel Jeffrey | EVP and General Counsel | Award / Grant | 57,135 | — | — | 646,248 | Mar 4, 2021 |
| Senner Christopher J. | EVP and CFO | Award / Grant | 64,150 | — | — | 356,591 | Mar 4, 2021 |
| Haley Patrick J. | EVP, Commercial | Award / Grant | 59,570 | — | — | 305,057 | Mar 4, 2021 |
| Lamb Peter | EVP, Scientific Strategy & CSO | Award / Grant | 49,395 | — | — | 389,467 | Mar 4, 2021 |
| Lamb Peter | EVP, Scientific Strategy & CSO | Sale | 65,000 | $22.11 | $1,437,150 | 340,072 | Mar 1, 2021 |
| MORRISSEY MICHAEL | President and CEO | Gift | 67,374 | — | — | 491,813 | Feb 24, 2021 |
| COHEN CHARLES | — | Option Exercise | 40,000 | $3.38 | $135,200 | 221,375 | Feb 24, 2021 |
| WILLSEY LANCE | — | Sale | 800 | $22.34 | $17,872 | 424,415 | Feb 23, 2021 |
| POSTE GEORGE | — | Option Exercise | 40,000 | $3.38 | $135,200 | 197,992 | Feb 22, 2021 |
| MARCHESI VINCENT T | — | Sale | 24,097 | $22.29 | $537,122 | 66,115 | Feb 22, 2021 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Option Exercise | 50,000 | $1.70 | $85,000 | 590,597 | Feb 17, 2021 |
| FELDBAUM CARL B | — | Option Exercise | 20,000 | $3.38 | $67,600 | 28,521 | Feb 16, 2021 |
| Senner Christopher J. | EVP and CFO | Tax Withholding | 4,105 | $21.91 | $89,941 | 292,441 | Feb 15, 2021 |
| Hessekiel Jeffrey | EVP and General Counsel | Tax Withholding | 1,685 | $21.91 | $36,918 | 589,113 | Feb 15, 2021 |
| Schwab Gisela | Pres, Prod Dev & Med Aff & CMO | Tax Withholding | 2,858 | $21.91 | $62,619 | 540,597 | Feb 15, 2021 |